-
FDA Grants Accelerated Approval to Datroway for Previously Treated EGFR-Mutated Lung Cancer
01 Jul 2025 21:19 GMT
… or metastatic non-small cell lung cancer (NSCLC) with an … AstraZeneca and Daiichi Sankyo.
Lung cancer is the leading cause of … for advanced EGFR-mutated lung cancer. About 4% of patients … Datroway to docetaxel in 590 patients with advanced lung cancer who had …
-
A Systematic Review of SNPs Screening for Platinum-Related Pharmacodynamics and Pharmacokinetics Genes in Non-Small Cell Lung Cancer for Precision Medicine
26 Jun 2025 22:33 GMT
… docetaxel-cisplatin-treated advanced non-small-cell lung cancer. … lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. … non-small cell lung cancer patients. Lung Cancer. 2011;72( … lung cancer: 2009 looking toward 2012. Chin J Lung Cancer. …
-
AZ, Daiichi get Datroway nod in lung cancer on second try
24 Jun 2025 22:24 GMT
… from the FDA for a lung cancer indication, seven months after withdrawing … approved in the US for lung cancer.
The ADC is already being … prior therapy when compared with docetaxel, a standard form of chemotherapy …
-
DATROWAY® approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
24 Jun 2025 11:26 GMT
… cell lung cancer
Nearly 2.5 million lung cancer cases … docetaxel. OS results were presented at IASLC 2024 World Conference on Lung Cancer … non-small cell lung cancer. Translational Lung Cancer Research. 2015;4 … in non-small lung cancers and its correlation …
-
FDA Approves Datopotamab for Treatment of EGFR-Mutated Non-Small Cell Lung Cancer
23 Jun 2025 21:38 GMT
… or metastatic non-small cell lung cancer with actionable genomic alterations (TROPION … versus docetaxel in previously treated advanced or metastatic non-small cell lung cancer … EGFR-mutated non-small cell lung cancer. AstraZeneca. December 9, 2024. Accessed …
-
DATROWAY® Approved in the U.S. as First TROP2 Directed Therapy for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
23 Jun 2025 21:09 GMT
… with advanced EGFR-mutated lung cancer whose disease has … safety of DATROWAY versus docetaxel in adult patients with … breast cancer, small cell lung cancer, urothelial, gastric, pancreatic, … Small Cell Lung Cancer
Nearly 2.5 million lung cancer cases were …
-
Practice-Changing Lung Cancer Data From The 2025 ASCO Annual Meeting
23 Jun 2025 19:29 GMT
… non–small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) breakthroughs.
… OSE2101 versus docetaxel in patients with metastatic non–small cell lung cancer and … OSE2101 versus docetaxel in patients with metastatic non-small cell lung cancer and …
-
Synergy between SH-003 and docetaxel against refractory lung cancer
16 Jun 2025 15:10 GMT
Cancer
Lung cancer is globally the second most frequent cancer and the cause of approximately 2 of every 10 cancer-related deaths. Immune checkpoint inhibitor therapy can be effective for some patients, but many patients prove resistant to it.
BioWorld …
-
EGFR-mutated non-small cell lung cancer
05 Jun 2025 22:58 GMT
… cases of non-small cell lung cancer (NSCLC) in non- … either sacituzumab tirumotecan or docetaxel as standard of care. … with only 16% with docetaxel; median progression-free survival … Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations …
-
Innovent’s IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer
05 Jun 2025 02:42 GMT
… squamous non-small cell lung cancer (sqNSCLC) who previously … registrational clinical trials for lung cancer and colorectal cancer, … Non-Small Cell Lung Cancer (sqNSCLC)
Lung cancer is the most … or third-line treatment, docetaxel, offers limited efficacy, with …
About
© 1995-2025